Front Row Advisors »

Eagle Pharmaceuticals shares owned by Front Row Advisors

Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Front Row Advisors from 13F filings

Historical chart of Front Row Advisors investment in Eagle Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eagle Pharmaceuticals held by Front Row Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eagle Pharmaceuticals by Front Row Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $209 40 5.23
2023-09-30 $631 40 15.78
2023-06-30 $1.0k 40 25.00
2023-03-31 $4 1 4.00
2022-09-30 $1.0k 40 25.00
2022-06-30 $2.0k 40 50.00
2022-03-31 $2.0k 40 50.00
2021-12-31 $2.0k 40 50.00
2021-09-30 $2.0k 40 50.00
2021-06-30 $2.0k 40 50.00
2021-03-31 $2.0k 40 50.00
2020-12-31 $2.0k 40 50.00
2020-09-30 $2.0k 40 50.00
2020-06-30 $2.0k 40 50.00
2020-03-31 $2.0k 40 50.00
2019-12-31 $2.0k 40 50.00
2019-09-30 $2.0k 40 50.00
2019-06-30 $2.0k 40 50.00
2019-03-31 $2.0k 40 50.00